Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study

Subsai Kongsaengdao1 Division of Neurology, Department of Medicine, Rajavithi Hospital, Department of Medical Services, Public Health Ministry, Bangkok, Thailand;2 Department of Medicine, College of Medicine, Rangsit University, Bangkok, ThailandCorrespondence[email protected]

Narong Maneeton3 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Benchalak Maneeton3 Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Pages 1119-1124 | Published online: 26 Apr 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KongsaengdaoSManeetonBManeetonNQuality of life in cervical dystonia after treatment with botulinum toxin A: a 24-week prospective studyNeuropsychiat Dis Treat201713127132
Web of Science ®Google Scholar
JagotaPKaewwilaiLBoonrodNImpact of neu-botulinum-toxinA on the severity and quality of life of cervical dystonia patientsTremor Other Hyperkinet Move20166407
PubMed Web of Science ®Google Scholar
JankovicJTreatment of dystoniaLancet Neurol200651086487216987733
PubMed Web of Science ®Google Scholar
ComellaCLThompsonPDTreatment of cervical dystonia with botulinum toxinsEur J Neurol200613Suppl 1162016417593
PubMed Web of Science ®Google Scholar
ChanJBrinMFFahnSIdiopathic cervical dystonia: clinical characteristicsMov Disord1991621191262057004
PubMed Web of Science ®Google Scholar
de Carvalho AguiarPMOzeliusLJClassification and genetics of dystoniaLancet Neurol20021531632512849429
PubMed Web of Science ®Google Scholar
BressmanSBGreenePEDystoniaCurr Treat Options Neurol20002327528511096754
PubMedGoogle Scholar
Epidemiological Study of Dystonia in Europe Collaborative GroupA prevalence study of primary dystonia in eight European countriesJ Neurol20002471078779211127535
PubMed Web of Science ®Google Scholar
SlawekJFriedmanAPotulskaAFactors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injectionsFunct Neurol20072229510017637212
PubMed Web of Science ®Google Scholar
CostaJEspirito-SantoCBorgesAFerreiraJJCoelhoMSampaioCBotulinum toxin type A versus anticholinergics for cervical dystoniaCochrane Database Syst Rev20051CD004312
Google Scholar
WalkerFOBotulinum toxin therapy for cervical dystoniaPhys Med Rehabili Clin N Am2003144749766vi
Google Scholar
SimpsonDMBlitzerABrashearAAssessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologyNeurology200870191699170618458230
PubMed Web of Science ®Google Scholar
FerreiraJJCostaJCoelhoMSampaioCThe management of cervical dystoniaExpert Opin Pharmacother20078212914017257084
PubMed Web of Science ®Google Scholar
BrashearAThe botulinum toxins in the treatment of cervical dystoniaSem Neurol20012118590
Web of Science ®Google Scholar
CanoSJHobartJCEdwardsMCDIP-58 can measure the impact of botulinum toxin treatment in cervical dystoniaNeurology200667122230223217190951
PubMed Web of Science ®Google Scholar
BransJWLindeboomRAramidehMSpeelmanJDLong-term effect of botulinum toxin on impairment and functional health in cervical dystoniaNeurology1998505146114639596007
PubMed Web of Science ®Google Scholar
PekmezovicTSvetelMIvanovicNQuality of life in patients with focal dystoniaClin Neurol Neurosurg2009111216116418995953
PubMed Web of Science ®Google Scholar
HakkinenAYlinenJRinta-KeturiMTalvitieUKautiainenHRissanenADecreased neck muscle strength is highly associated with pain in cervical dystonia patients treated with botulinum toxin injectionsArch Phy Med Rehab2004851016841688
Web of Science ®Google Scholar
HilkerRSchischniaschviliMGhaemiMJacobsARudolfJHealth related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystoniaJ Neurol Neurosurg Psychiatry200171219319911459891
PubMed Web of Science ®Google Scholar
WenzelTSchniderPWimmerASteinhoffNMoraruEAuffEPsychiatric comorbidity in patients with spasmodic torticollisJ Psychosom Res19984466876909678750
PubMed Web of Science ®Google Scholar
AlbaneseAAsmusFBhatiaKPEFNS guidelines on diagnosis and treatment of primary dystoniasEur J Neurol201118151820482602
PubMed Web of Science ®Google Scholar
AlbaneseABarnesMPBhatiaKPA systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task ForceEur J Neurol200613543344416722965
PubMed Web of Science ®Google Scholar
PoungvarinNViriyavejakulABotulinum A toxin treatment in spasmodic torticollis: report of 56 patientsJ Med Assoc Thai19947794644707706965
PubMedGoogle Scholar
BhidayasiriRTreatment of complex cervical dystonia with botulinum toxin: involvement of deep-cervical muscles may contribute to suboptimal responsesParkinsonism Relat Disord201117Suppl 1S20S2421999891
PubMed Web of Science ®Google Scholar
HefterHBeneckeRErbguthFJostWReichelGWisselJAn open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)BMJ Open201334e001853
Web of Science ®Google Scholar
SkogseidIMMaltUFRoislienJKertyEDeterminants and status of quality of life after long-term botulinum toxin therapy for cervical dystoniaEur J Nurol2007141011291137
Web of Science ®Google Scholar
MordinMMasaquelCAbbottCCopley-MerrimanCFactors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinum toxin A (Dysport): results from a randomised, double-blind, placebo-controlled studyBMJ Open2014410e005150
Web of Science ®Google Scholar
RadloffLSA self-report depression scale for research in the general populationAppl Psychol Meas19771385401
Web of Science ®Google Scholar
BlankKGrumanCRobisonJTCase-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settingsJ Gerontol A Biol Sci Med Sci200459437838415071082
PubMed Web of Science ®Google Scholar
TrangkasombatULikanapichitkulDThe Children’s Depression Inventory as a screen for depression in Thai childrenJ Med Assoc Thai19978084914999277081
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term quality of life in cervical dystonia after treatment with abobotulinum toxin A: a 2-year prospective study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date